Literature DB >> 29523332

An IclR like protein from mycobacteria regulates leuCD operon and induces dormancy-like growth arrest in Mycobacterium smegmatis.

Rajendra Kumar Angara1, Suhail Yousuf2, Shailesh Kumar Gupta3, Akash Ranjan4.   

Abstract

leuCD operon encodes isopropylmalate isomerase (IPMI), an essential enzyme in leucine biosynthesis. Leucine biosynthesis is one of the essential metabolic pathways for Mycobacterium tuberculosis survival inside the macrophage. In this study, we identified an IclR like transcription regulator, Rv2989 involved in regulation of leuCD expression. Further, we have shown that the Rv2989 binding site overlaps with the promoter region of leuCD, indicating its direct involvement in the regulation of this operon. Ectopic expression of Rv2989 in M. smegmatis induced growth arrest with significantly decreased levels of leuCD transcript. However, supplementation with leucine could not reverse the growth arrest, suggesting the involvement of Rv2989 in the regulation of other essential pathways. Growth-arrested cells were elongated, had lost acid fastness and accumulated lipid droplets similar to a dormancy-like state. In conclusion, the Rv2989 expression has pleiotropic effects on M. smegmatis. It negatively regulates leuCD operon and induces dormancy-like growth arrest.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dormancy; IclR like protein; Leucine biosynthesis; Lipid droplets; Mycobacteria

Mesh:

Substances:

Year:  2017        PMID: 29523332     DOI: 10.1016/j.tube.2017.10.009

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  1 in total

1.  Mycolicibacterium smegmatis, Basonym Mycobacterium smegmatis, Expresses Morphological Phenotypes Much More Similar to Escherichia coli Than Mycobacterium tuberculosis in Quantitative Structome Analysis and CryoTEM Examination.

Authors:  Hiroyuki Yamada; Masashi Yamaguchi; Yuriko Igarashi; Kinuyo Chikamatsu; Akio Aono; Yoshiro Murase; Yuta Morishige; Akiko Takaki; Hiroji Chibana; Satoshi Mitarai
Journal:  Front Microbiol       Date:  2018-09-11       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.